Goldman Sachs’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $451K | Buy |
|
|||||
|
2024
Q1 | $214K | Sell |
|
|||||
|
2023
Q4 | $472K | Buy |
|
|||||
|
2023
Q3 | $431K | Buy |
|
|||||
|
2023
Q2 | $174K | Sell |
|
|||||
|
2023
Q1 | $429K | Buy |
|
|||||
|
2022
Q4 | $162K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $84K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $184K | Sell |
|
|||||
|
2018
Q4 | $102K | Sell |
|
|||||
|
2018
Q3 | $387K | Sell |
|
|||||
|
2018
Q2 | $669K | Buy |
|
|||||
|
2018
Q1 | $232K | Sell |
|
|||||
|
2017
Q4 | $396K | Sell |
|
|||||
|
2017
Q3 | $1.58M | Buy |
|
|||||
|
2017
Q2 | $1.13M | Sell |
|
|||||
|
2017
Q1 | $3.9M | Buy |
|
|||||
|
2016
Q4 | $660K | Buy |
|
|||||
|
2016
Q3 | $762K | Buy |
|
|||||
|
2016
Q2 | $595K | Buy |
|
|||||
|
2016
Q1 | $499K | Buy |
|
|||||
|
2015
Q4 | $229K | Sell |
|
|||||
|
2015
Q3 | $1.59M | Sell |
|
|||||
|
2015
Q2 | $3.3M | Sell |
|
|||||
|
2015
Q1 | $3.38M | Sell |
|
|||||
|
2014
Q4 | $3.48M | Sell |
|
|||||
|
2014
Q3 | $2.72M | Sell |
|
|||||
|
2014
Q2 | $4.8M | Buy |
|
|||||
|
2014
Q1 | $1M | Buy |
|
|||||
|
2013
Q4 | $920K | Buy |
|
|||||
|
2013
Q3 | $615K | Buy |
|
|||||
|
2013
Q2 | $1.04M | Buy |
|